NCT00836823View on ClinicalTrials.gov

Evaluation of Symptom-specific Goal Achievement

PHASE4CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Benign Prostatic HyperplasiaLower Urinary Tract Symptoms
Interventions
DRUG

Alfuzosin

Alfuzosin 10mg once daily for 12 months

Trial Locations (2)

Unknown

Asan Medical Center, Ulsan College of Medicine, Seoul

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT00836823 - Evaluation of Symptom-specific Goal Achievement | Biotech Hunter | Biotech Hunter